GB201421010D0 - Method - Google Patents

Method

Info

Publication number
GB201421010D0
GB201421010D0 GBGB1421010.8A GB201421010A GB201421010D0 GB 201421010 D0 GB201421010 D0 GB 201421010D0 GB 201421010 A GB201421010 A GB 201421010A GB 201421010 D0 GB201421010 D0 GB 201421010D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1421010.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
N-Gene Research Laboratories Inc
Original Assignee
N-Gene Research Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by N-Gene Research Laboratories Inc filed Critical N-Gene Research Laboratories Inc
Priority to GBGB1421010.8A priority Critical patent/GB201421010D0/en
Publication of GB201421010D0 publication Critical patent/GB201421010D0/en
Priority to PCT/GB2015/053608 priority patent/WO2016083815A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
GBGB1421010.8A 2014-11-26 2014-11-26 Method Ceased GB201421010D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1421010.8A GB201421010D0 (en) 2014-11-26 2014-11-26 Method
PCT/GB2015/053608 WO2016083815A1 (en) 2014-11-26 2015-11-26 Hydroxylamine derivatives for use in the treatment of arrhythmia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1421010.8A GB201421010D0 (en) 2014-11-26 2014-11-26 Method

Publications (1)

Publication Number Publication Date
GB201421010D0 true GB201421010D0 (en) 2015-01-07

Family

ID=52292564

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1421010.8A Ceased GB201421010D0 (en) 2014-11-26 2014-11-26 Method

Country Status (2)

Country Link
GB (1) GB201421010D0 (en)
WO (1) WO2016083815A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004300102A (en) * 2003-03-31 2004-10-28 Kissei Pharmaceut Co Ltd Condensed heterocyclic derivative, pharmaceutical composition containing the same and its pharmaceutical application

Also Published As

Publication number Publication date
WO2016083815A1 (en) 2016-06-02

Similar Documents

Publication Publication Date Title
GB201417712D0 (en) Method
GB201406151D0 (en) Method
GB201418159D0 (en) Method
GB201409558D0 (en) Method
GB201406155D0 (en) Method
GB201408119D0 (en) Method
GB201414496D0 (en) Method
GB201417042D0 (en) Method
GB201413240D0 (en) Method
GB201403470D0 (en) Method
GB201410022D0 (en) Method
GB201410101D0 (en) Method
GB201416675D0 (en) Method
GB201412802D0 (en) Method
GB201411500D0 (en) Method
GB201409128D0 (en) Method
GB201416849D0 (en) Method
GB201412736D0 (en) Method
GB201412226D0 (en) Method
GB201409234D0 (en) Method
GB201409101D0 (en) Method
GB201414181D0 (en) Method
GB201413929D0 (en) Method
GB201413612D0 (en) Method
GB201408649D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)